このページは自動翻訳されたものであり、翻訳の正確性は保証されていません。を参照してください。 英語版 ソーステキスト用。

Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses

2026年8月17日 更新者：Ang Wei How Darryl、National University of Singapore

Platform for End-of-life Awareness, Conversations, and Education (PEACE) Among Registered Nurses: A Mixed Methods Study

The goal of this clinical trial is to evaluate whether the PEACE program can improve early career registered nurses' registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death, and self-efficacy in initiating advanced care planning conversations

This study aims to address the following research questions:

  • Does the PEACE program improve early career registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations?
  • What are the participants' experiences of participating in the PEACE program?

Researchers will compare participants who receive the PEACE program (death conversation and online ACP education) with participants who receive only the online ACP education to see if informal death conversations improve early career registered nurses' attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations.

Participants will:

  • Complete online questionnaires measuring attitudes towards caring for palliative patients, ability to cope with patients' death and self-efficacy in initiating advanced care planning conversations.
  • Participate in a facilitator-led group discussion session about experiences of patients' deaths, coping with patients' death and dying, communications with patients and/or family members about death and dying, and discussing advance care planning with patients and/or family members (intervention group only).
  • Complete an asynchronous online ACP education session consisting of short recorded videos and an online discussion forum (both intervention and control group).
  • Complete follow-up surveys, including a 3-month follow-up assessing whether participants have engage with any patients and/or their family members in advance care planning conversations.

調査の概要

状態

まだ募集していません

条件

介入・治療

研究の種類

介入

入学 (推定)

150

段階

  • 適用できない

連絡先と場所

このセクションには、調査を実施する担当者の連絡先の詳細と、この調査が実施されている場所に関する情報が記載されています。

研究連絡先

研究場所

参加基準

研究者は、適格基準と呼ばれる特定の説明に適合する人を探します。これらの基準のいくつかの例は、人の一般的な健康状態または以前の治療です。

適格基準

就学可能な年齢

  • 大人
  • 高齢者

健康ボランティアの受け入れ

はい

説明

Inclusion Criteria:

  • Registered nurses within the first five years of practice
  • Between the ages of 21 to 65 years
  • Currently working in a healthcare setting in SIngapore

Exclusion Criteria:

  • Participated in a similar death conversation program
  • Received training in Advance Care Planning or Serious Illness Conversations
  • Any self-reported history of mental health disorders (e.g., depression), or neurological disorders (e.g., brain tumors)

研究計画

このセクションでは、研究がどのように設計され、研究が何を測定しているかなど、研究計画の詳細を提供します。

研究はどのように設計されていますか？

デザインの詳細

  • 主な目的：防止
  • 割り当て：ランダム化
  • 介入モデル：並列代入
  • マスキング：なし（オープンラベル）

武器と介入

参加者グループ / アーム
介入・治療
実験的：Intervention Group - on site group discussions + online learning session

Participants in this arm will receive the two-session PEACE Program.

Session 1 is an on site, facilitator-led group discussion lasting 2 hours, covering:

  1. Experiences of death and dying
  2. Coping with death and dying.
  3. Communication about death and dying
  4. Discussing Advance Care Planning (ACP).

Session 2 is an online asynchronous learning session with short videos on ACP with discussion forums.
行動：オンラインACP教育
ACPに関する短い動画とディスカッションフォーラムを備えたオンライン非同期学習セッション。
行動：Death Conversation
On site, facilitator-led group discussion lasting 2 hours, covering: 1) Experiences of patients' deaths; 2) Coping with patients' death and dying; 3) Communication with patients and/or family members about death and dying; 4) Discussing advance care planning with patients and/or family members
アクティブコンパレータ：Control Group - Only online learning session
Participants in this arm will only receive the online ACP education component, identical to Session 2 of the PEACE programme. No facilitator-led group discussions are provided.
行動：オンラインACP教育
ACPに関する短い動画とディスカッションフォーラムを備えたオンライン非同期学習セッション。

この研究は何を測定していますか？

主要な結果の測定

結果測定
メジャーの説明
時間枠
Frommelt Attitude Toward Care of the Dying Scale
時間枠：Baseline
A 30-item 5 point Likert scale. Positive items are scored one (strongly disagree) to five (strongly agree). Scores are reversed for negative items. Possible scores can range from 30-150. A higher score indicates a more positive attitude toward caring for this patient population.
Baseline
Frommelt Attitude Toward Care of the Dying Scale
時間枠：Post-test (Immediately at end of 2-weeks intervention)
A 30-item 5 point Likert scale. Positive items are scored one (strongly disagree) to five (strongly agree). Scores are reversed for negative items. Possible scores can range from 30-150. A higher score indicates a more positive attitude toward caring for this patient population.
Post-test (Immediately at end of 2-weeks intervention)
Frommelt Attitude Toward Care of the Dying Scale
時間枠：3 months follow-up
A 30-item 5 point Likert scale. Positive items are scored one (strongly disagree) to five (strongly agree). Scores are reversed for negative items. Possible scores can range from 30-150. A higher score indicates a more positive attitude toward caring for this patient population.
3 months follow-up

二次結果の測定

結果測定
メジャーの説明
時間枠
Palliative care self-efficacy scale
時間枠：Baseline
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently). Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
Baseline
Palliative care self-efficacy scale
時間枠：Post-test (Immediately at end of 2-weeks intervention)
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently). Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
Post-test (Immediately at end of 2-weeks intervention)
Palliative care self-efficacy scale
時間枠：3 months follow-up
A twelve item 4-point Likert scale, scored from 1 (Need further basic instruction) to 4 (Confident to perform independently). Higher scores indicate nurses having higher degree of confidence with the respective patient/family interactions and patient management topics.
3 months follow-up
Advance Care Planning Self-Efficacy (ACP-SE) Scale
時間枠：Baseline
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
Baseline
Advance Care Planning Self-Efficacy (ACP-SE) Scale
時間枠：Post-test (Immediately at end of 2-weeks intervention)
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
Post-test (Immediately at end of 2-weeks intervention)
Advance Care Planning Self-Efficacy (ACP-SE) Scale
時間枠：3 months follow-up
An 18-item 5-point Likert scale, scored from 1 (Not at all confident) to 5 (Very confident), with higher scores indicating more confidence in performing respective tasks regarding Advance Care Planning (ACP) conversations for patients.
3 months follow-up
End-of-life planning conversations
時間枠：3 months follow-up
Self-reported number of conversations held with patients regarding Advance Care Planning
3 months follow-up

協力者と研究者

ここでは、この調査に関係する人々や組織を見つけることができます。

スポンサー

National University of Singapore

研究記録日

これらの日付は、ClinicalTrials.gov への研究記録と要約結果の提出の進捗状況を追跡します。研究記録と報告された結果は、国立医学図書館 (NLM) によって審査され、公開 Web サイトに掲載される前に、特定の品質管理基準を満たしていることが確認されます。

主要日程の研究

研究開始 (推定)

2026年9月1日

一次修了 (推定)

2027年12月31日

研究の完了 (推定)

2027年12月31日

試験登録日

最初に提出

2026年8月11日

QC基準を満たした最初の提出物

2026年8月17日

最初の投稿 (実際)

2026年8月19日

学習記録の更新

投稿された最後の更新 (実際)

2026年8月19日

QC基準を満たした最後の更新が送信されました

2026年8月17日

最終確認日

2026年8月1日

詳しくは

本研究に関する用語

キーワード

追加の関連 MeSH 用語

その他の研究ID番号

  • NUS-DERC-001647
  • A-0010425-00-00 (その他の助成金/資金番号：National University of Singapore)

医薬品およびデバイス情報、研究文書

米国FDA規制医薬品の研究

いいえ

米国FDA規制機器製品の研究

いいえ

この情報は、Web サイト clinicaltrials.gov から変更なしで直接取得したものです。研究の詳細を変更、削除、または更新するリクエストがある場合は、register@clinicaltrials.gov。 までご連絡ください。 clinicaltrials.gov に変更が加えられるとすぐに、ウェブサイトでも自動的に更新されます。

購読する